Quarter Financials
Novartis AG (NVS)
$97.86
+0.08 (+0.08%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | 1,466 | 1,573 | 1,694 | 2,222 | 16,308 | 2,758 | 2,896 | 2,059 |
|---|
| Dividend Paid | - | - | - | -7,506 | - | - | - | -7,368 |
|---|
| Retained Earnings | - | - | - | - | - | - | - | - |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -647 | -582 | -583 | -859 | -977 | -539 | -597 | -858 |
|---|
| Net PPE | 12,195 | 11,731 | 12,206 | 12,861 | 13,106 | 13,157 | 13,344 | 13,204 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | -86 | -87 | -807 | -15,634 | -4,256 | -13,271 | -6,710 | -10,579 |
|---|
| Intangible and Goodwill | 29,590 | 29,766 | 29,572 | 29,595 | 29,636 | 29,113 | 28,668 | 29,301 |
|---|